Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
9 Months Ended
Dec. 17, 2021
Sep. 30, 2023
May 18, 2023
Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]        
cash $ 979,690 $ 123,724   $ 299,149
Cash equivalents   $ 0   $ 0
Term of restricted investments   185 days    
Investment interest rate     4.65%  
Cash insured with federal insurance corporation   $ 250,000    
Common Class A [Member]        
Subsidiary, Sale of Stock [Line Items]        
Ordinary shares subject to possible redemption   11,436,925   34,500,000
IPO [Member]        
Subsidiary, Sale of Stock [Line Items]        
Stock issuance costs   $ 7,607,233    
Payments for underwriting expense   6,900,000    
Other offering costs $ 707,233 707,233    
Offering expenses related to warrant issuance   $ 321,236